Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2026)

Viemed Healthcare (VMD) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $204.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 10.63% year-over-year to $204.2 million; the trailing twelve-month figure through Jun 2026 stood at $803.1 million (up 13.23% YoY), and the FY2025 full-year result was $199.2 million, up 12.47% from the prior year.
• Liabilities and Shareholders Equity climbed to $204.2 million in Q2 2026 per VMD's latest filing, from $197.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $204.2 million in Q2 2026 and bottomed at $115.9 million in Q2 2022.
• Historically, Liabilities and Shareholders Equity has averaged $160.0 million across 5 years, with a median of $159.4 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity retreated 0.78% in 2022, then surged 32.34% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $117.0 million in 2022, then jumped by 32.34% to $154.9 million in 2023, then advanced by 14.32% to $177.1 million in 2024, then grew by 12.47% to $199.2 million in 2025, then grew by 2.55% to $204.2 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $204.2 million, $197.4 million, and $199.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.